Johanna Friedl-Naderer - Mar 3, 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
EVP & Chief Operating Officer
Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Mar 3, 2023
Transactions value $
-$33,819
Form type
4
Date filed
3/7/2023, 01:04 PM
Previous filing
Feb 24, 2023
Next filing
Sep 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Sale -$33.8K -1.48K -0.99% $22.82 149K Mar 3, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.